NAD+ vs Epithalon: Longevity Peptides Compared

NAD+ (nicotinamide adenine dinucleotide) and Epithalon target two of the nine recognised hallmarks of aging. NAD+ addresses mitochondrial dysfunction — as NAD+ levels decline with age, mitochondrial energy production decreases, sirtuin activity drops, and DNA repair capacity diminishes. Epithalon addresses telomere attrition — as telomeres shorten with each cell division, cells enter senescence and lose regenerative capacity. Restoring NAD+ levels supports immediate cellular energy and repair, while Epithalon's telomerase activation supports long-term replicative capacity in test subjects. For research purposes only.

Aging hallmark targeted: NAD+ = Mitochondrial dysfunction | Epithalon = Telomere attrition Mechanism: NAD+ = Coenzyme restoration, sirtuin activation | Epithalon = Telomerase activation Molecule type: NAD+ = Coenzyme (not a peptide) | Epithalon = Tetrapeptide Dose: NAD+ = 50-100 mg daily (SubQ) | Epithalon = 5 mg daily Cycle: NAD+ = 4-8 weeks on, 2-4 weeks off | Epithalon = 10-20 days, then 4-6 months off Vial sizes: NAD+ = 500mg, 1000mg | Epithalon = 10mg Onset of effects: NAD+ = Days (energy) | Epithalon = Weeks-months (cellular) Immediate benefits: NAD+ = Yes (energy, clarity) | Epithalon = No (long-term cellular) Long-term benefits: NAD+ = Moderate | Epithalon = Potentially significant Cost per cycle: NAD+ = Higher (large doses) | Epithalon = Lower (short cycles)

Choose NAD+ when: The research investigates mitochondrial function restoration, sirtuin biology, or immediate cellular energy enhancement. NAD+ produces noticeable effects on energy and cognitive clarity relatively quickly in test subjects. Choose Epithalon when: The research focuses on telomere biology, telomerase activation, or long-term cellular replicative capacity. Epithalon's effects are more subtle and long-term but potentially more fundamental to aging in test subjects. Both compounds are frequently combined in longevity research protocols — NAD+ for immediate mitochondrial support and Epithalon for long-term telomere maintenance. They target different aging mechanisms and do not interfere with each other. For research purposes only.